Admission Date:  [**2147-5-16**]              Discharge Date:   [**2147-5-25**]  Date of Birth:  [**2093-11-1**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 4393**] Chief Complaint: abdominal pain  Major Surgical or Invasive Procedure: EGD [**Last Name (un) **] tube TIPS placement   History of Present Illness: Patient is a 53yo male with hepatitis C cirrhosis, ascites, encephalopathy admitted on [**2147-5-16**] with abdominal pain [**1-10**] SBP, treated with ceftriaxone.
Patient started on octreotide gtt, pantoprazole and sucralfate.
Trauma line has been removed this morning after Hct has been stable at 28-30 for greater than two days.
He reports last using heroin 3 weeks ago.
Family History: Maternal grandfather with CAD/PVD; mother with DM  Physical Exam: VS - afebrile, 114/61 , HR 76 , 20 R , O2-sat 98% RA GENERAL - jaundiced-appearing man in NAD, comfortable, appropriate HEENT - NC/AT, PERRLA, EOMI, sclerae icteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - CTA anteriorly HEART - PMI non-displaced, RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft/NT, distended, no masses or HSM, no rebound/guarding EXTREMITIES - WWP, 2+ pitting edema to knees, 2+ peripheral pulses (radials, DPs) SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, A&Ox3, CNs II-XII grossly intact  Pertinent Results: [**2147-5-16**] 03:10AM   PT-19.8* PTT-36.4* INR(PT)-1.8* [**2147-5-16**] 03:10AM   PLT COUNT-84* [**2147-5-16**] 03:10AM   NEUTS-76.3* LYMPHS-14.8* MONOS-5.1 EOS-3.5 BASOS-0.3 [**2147-5-16**] 03:10AM   WBC-7.7 RBC-3.48* HGB-11.5* HCT-33.2* MCV-96 MCH-33.2* MCHC-34.7 RDW-16.6* [**2147-5-16**] 03:10AM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2147-5-16**] 03:10AM   ALBUMIN-2.4* [**2147-5-16**] 03:10AM   LIPASE-38 [**2147-5-16**] 03:10AM   ALT(SGPT)-39 AST(SGOT)-71* ALK PHOS-94 TOT BILI-4.1* [**2147-5-16**] 03:10AM   estGFR-Using this [**2147-5-16**] 03:10AM   GLUCOSE-158* UREA N-35* CREAT-1.4* SODIUM-139 POTASSIUM-4.0 CHLORIDE-107 TOTAL CO2-24 ANION GAP-12 [**2147-5-16**] 03:15AM   LACTATE-1.7 [**2147-5-16**] 05:10AM URINE  RBC-0-2 WBC-[**2-10**] BACTERIA-FEW YEAST-NONE EPI-0 [**2147-5-16**] 05:10AM URINE  BLOOD-TR NITRITE-NEG PROTEIN-30 GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-4* PH-5.0 LEUK-NEG [**2147-5-16**] 05:10AM URINE  COLOR-Amber APPEAR-Clear SP [**Last Name (un) 155**]-1.023 [**2147-5-16**] 05:10AM URINE  GR HOLD-HOLD [**2147-5-16**] 05:10AM URINE  UHOLD-HOLD [**2147-5-16**] 05:10AM URINE  HOURS-RANDOM [**2147-5-16**] 05:10AM URINE  HOURS-RANDOM [**2147-5-16**] 06:00AM ASCITES  WBC-825* RBC-1675* POLYS-56* LYMPHS-31* MONOS-0 MESOTHELI-2* MACROPHAG-11* [**2147-5-16**] 06:00AM ASCITES  TOT PROT-0.9 GLUCOSE-160 LD(LDH)-62 ALBUMIN-<1.0  Labs at discharge:  WBC   RBC   Hgb   Hct  MCV MCH   MCHC  RDW  Plt Ct 10.3 3.21* 10.6* 29.6* 92  32.9* 35.6* 20.3*  82*  INR 3.1  Glucose UreaN Creat  Na  K   Cl HCO3 AnGap   143     14   0.5  137 3.8 108  22   11  ALT AST    AlkPhos  TotBili DirBili IndBili  38  86*     70       22.2*   13.2    9.0  Albumin Calcium Phos  Mg   2.4*    7.2*  1.8*  1.9  AFP 4.2  HIV negative  ASCITES ANALYSIS    WBC  RBC  Polys Lymphs Monos Eos Atyps Mesothe [**2147-5-25**] 08:11    440* 630*  11*   62*     5*   1*   1*    4*  [**2147-5-16**] 06:00    825* 1675* 56*   31*     0         2*    11*   MR abdomen: IMPRESSION:  1.
A site suitable for percutaneous aspiration of ascites was marked on the right lower anterolateral abdominal wall with patient supine and probe held perpendicular to the skin surface.
Patient placed on octreotide gtt and sucralfate.
Massive transfusion protocol was initiated and he received 11U PRBCs as well as multiple units of FFP and platelets.
Once stablized, he underwent TIPS procedure with resulting drop in portal pressure from 28 to 10.
He remained intubated until [**5-21**].
Tolerated extubation well.
He had no new episodes of GI bleed and did not require any additional blood products while here.
# Variceal hemorrhage- status post TIPS, tolerated procedure well, with decrease in portocaval gradient from 28 mmHg to 10 mmHg (still elevated).
Started ciprofloxacin 500 mg daily for secondary prevention of SBP.
Upon admission, had genotyping, AFP level, HIV test, hepatitis B and A markers, and iron studies.
FEN - Sodium restricted diet/Renal diet    Medications on Admission: 1.
Senna 8.6 mg PO BID PRN 2.
Docusate Sodium 100 mg PO BID PRN 3.
Furosemide 20 mg PO BID 4.
Lactulose 30 mLs PO TID 5.
Gabapentin 300 mg PO Q8H 6.
Hydrocortisone 2.5 % Cream Apply rectally [**Hospital1 **] as needed for rash.
Sucralfate 1 gram Tablet Sig: One (1) Tablet PO three times a day: Take 1 hour after ciprofloxacin as can block drug effect.
Nadolol 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO once a day: Take in the morning.
Lactulose 10 gram/15 mL Syrup Sig: Thirty (30) ML PO BID (2 times a day).
Rifaximin 200 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
Spironolactone 50 mg Tablet Sig: Three (3) Tablet PO once a day.
Gabapentin 300 mg Capsule Sig: One (1) Capsule PO three times a day.
You also had a serious gastrointestinal bleed that required placement of a shunt in your liver called a TIPS.
We started you on a medication to help reduce the chance of another bleed.
CHANGES to your medications include: Decrease furosemide to 20mg daily START sucralfate three times a day START pantoprazole 40mg twice a day START nadolol 20mg daily START ciprofloxacin 500mg daily (take 1 hour prior to sucralfate) START rifaximin 200mg three times a day START spironolactone 150mg (3 tabs) daily  ** You will need to have your blood drawn on [**2147-5-29**].
